Exelixis Inc Unrecognized Tax Benefits, Interest on Income Taxes Expense
Exelixis Inc (EXEL) reported Unrecognized Tax Benefits, Interest on Income Taxes Expense of $4.00 thousand for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-02.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense · last filed 2016-02-29
- Exelixis Inc unrecognized tax benefits, interest on income taxes expense for fiscal 2014 was $4.00K, a 0.00% change from fiscal 2013.
- Exelixis Inc unrecognized tax benefits, interest on income taxes expense for fiscal 2013 was $4.00K, a 33.33% decline from fiscal 2012.
- Exelixis Inc unrecognized tax benefits, interest on income taxes expense for fiscal 2012 was $6.00K, a 33.33% decline from fiscal 2011.
- Exelixis Inc unrecognized tax benefits, interest on income taxes expense for fiscal 2011 was $9.00K.
| Period end | Unrecognized Tax Benefits, Interest on Income Taxes Expense 12 month |
|---|---|
| 2014-12-31 | $4.00K 10-K · filed 2015-03-02 |
| 2013-12-31 | $4.00K 10-K · filed 2016-02-29 |
| 2012-12-31 | $6.00K 10-K · filed 2014-02-20 |
| 2011-12-31 | $9.00K 10-K · filed 2014-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |